Kunle Odunsi
Inventor
Stats
- 0 US patents issued
- 10 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 10 US Applications Filed
- 29 Total Citation Count
- Feb 27, 2023 Most Recent Filing
- Sep 10, 2004 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| LUDWIG INSTITUTE FOR CANCER RESEARCH | 1
| 2010
|
| HEALTH RESEARCH, INC. | 1
| 2004
|
Inventor Addresses
| Address | Duration |
|---|---|
| Buffalo, NY, US | Nov 08, 12 - Nov 08, 12 |
| Oak Park, IL, US | Dec 12, 24 - Feb 20, 25 |
| Williamsville, NY | Aug 04, 05 - Aug 04, 05 |
| Williamsville, NY, US | Jan 28, 16 - Mar 28, 24 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 8 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
| B82Y: | SPECIFIC USES OR APPLICATIONS OF NANO-STRUCTURES; MEASUREMENT OR ANALYSIS OF NANO-STRUCTURES; MANUFACTURE OR TREATMENT OF NANO-STRUCTURES | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2025/0057,881 | 2025 | COMPOSITIONS AND METHODS FOR USE OF RECOMBINANT T CELL RECEPTORS AGAINST CLAUDIN 6 | 0 |
| 2024/0408,202 | 2024 | FOLATE RECEPTOR ALPHA -TARGETING BI-SPECIFIC T CELL ENGAGERS (BiTEs) AND USES THEREOF | 0 |
| 2024/0101,701 | 2024 | ANTIBODY-DERIVED T CELL ACTIVATING TECHNOLOGIES | 0 |
| 2022/0017,593 | 2022 | COMPOSITIONS AND METHODS FOR USE OF RECOMBINANT T CELL RECEPTORS FOR DIRECT RECOGNITION OF TUMOR ANTIGEN | 0 |
| 11155595 | 2021 | Compositions and methods for use of recombinant T cell receptors for direct recognition of tumor antigen | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.